Aortic valve replacement in a patient with sickle cell disease—Are we justified to perform surgery in the TAVI era?

Not all variants of SCD need the same management and this should be decided on a case‐by‐case basis. Heterozygous SCD patients can undergo cardiac surgery without the need for intraoperative exchange transfusions with good clinical outcomes.

Detalles Bibliográficos
Autores principales: Ravishankar, Ramanish, Turkistani, Leenah, Elghoneimy, Yasser, Manoly, Imthiaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387662/
https://www.ncbi.nlm.nih.gov/pubmed/34471536
http://dx.doi.org/10.1002/ccr3.4085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387662/
https://www.ncbi.nlm.nih.gov/pubmed/34471536
http://dx.doi.org/10.1002/ccr3.4085

Ejemplares similares